Federal Register Notice: FDA is seeking public comment on the proposed collection of information resulting from the guidance to manufacturers of veterinary and human drugs, including human biological drug products, on how to resolve disputes of scientific and technical issues relating to current good manufacturing practice (CGMP). Comments should be submitted by 10/10. To view this notice, click here.
